Market Overview

UPDATE: Oppenheimer Reiterates Outperform Rating, Lowers PT on Ctrip.com

Share:
Related CTRP
Analyst Sees Ctrip's Deal With eLong-Tencent 'Too Much For Qunar And Allies To Overcome'
Monday's After-Hours Movers Led By Ctrip.com, Texas Roadhouse And Tenet Healthcare
Ctrip now +9.9% post-earnings; company won't fully counter Qunar's price war (Seeking Alpha)

In a report published Wednesday, Oppenheimer Holdings reiterated its Outperform rating on Ctrip.com International (NASDAQ: CTRP) but lowered its price target from $30.00 to $25.00.

Oppenheimer noted, “CTRP reported better than expected 2Q results and provided 3Q revenue guidance that encompasses our and consensus estimates. While margins contracted year/year, they were roughly in line with our estimates. Competition in the Chinese OTA market appears to be intensifying. Management lowered its margin forecast again, suggesting more aggressive pricing and marketing efforts in 2H12. We are lowering EPS estimates to reflect lower margin assumptions while keeping revenue estimates largely unchanged (only adjusting for FX). We also have lowered our PT from $30 to $25 on lower estimates. While we remain bullish on long-term prospects of CTRP, the stock may remain range-bound near term, given unfavorable margin trends, heightened competition and macro uncertainty.”

Ctrip.com International closed on Tuesday at $14.90.

Latest Ratings for CTRP

DateFirmActionFromTo
Jun 2015Stifel NicolausDowngradesBuyHold
Jun 2015UBSInitiates Coverage onBuy
May 2015Guggenheim SecuritiesInitiates Coverage onBuy

View More Analyst Ratings for CTRP
View the Latest Analyst Ratings

Posted-In: Oppenheimer HoldingsAnalyst Color Price Target Analyst Ratings

 

Related Articles (CTRP)

Get Benzinga's Newsletters